Lee Tien-Li
SEC CIK 1940120 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | CEO, Dir, 10% | 1.55M | $623.3K | — | 7 | 2025-02-14 | 2025-12-11 |
Most active insiders at AARD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sun Nelson | See Remarks | $43.2K | $395.0K |
| 2 | Lee Tien-Li | CEO, Dir, 10% | $101.4K | — |
| 3 | Jones Bryan | COO | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 2025-12-11 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | P - Purchase | $14.49 | +7,000 | 1.55M | +0.5% | +$101.4K | |
| D | 2025-10-16 | 2025-10-15 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | M - OptEx | $4.24 | +1,229 | 1.54M | +0.1% | +$5,211 |
| M | 2025-09-16 | 2025-09-15 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | P - Purchase | $9.66 | +10.0K | 1.54M | +0.7% | +$96.6K |
| M | 2025-09-12 | 2025-09-10+ | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | P - Purchase | $8.03 | +20.0K | 1.53M | +1% | +$160.6K |
| D | 2025-08-29 | 2025-08-28 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | M - OptEx | $4.24 | +17.2K | 1.51M | +1% | +$73.0K |
| D | 2025-02-19 | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | P - Purchase | $16.00 | +16.5K | 1.50M | +1% | +$264.7K |
| D | 2025-02-19 | 2025-02-14 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | CEO, Dir, 10% | C - Cnv Deriv | — | +41.3K | 1.48M | +3% | — |
Purchase Sale Sale after option exercise All abbreviations